Semaglutide(Fujian Genohope Biotech)

司美格鲁肽(福建基诺厚普生物)

Report date: 2025/08/18 15:58:51

Base Information

Drug NameSemaglutide(Fujian Genohope Biotech)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityDyslipidemias +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFujian Genohope Biotech Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOverweightObesityDyslipidemias +[6
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A